Page 137 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 137

Genetic Aspects of Vasculitis   113

[91] Onouchi, Y., Ozaki, K., Burns, J. C., et al. A genome-wide association study identifies
       three new risk loci for Kawasaki disease. Nat. Genet. 2012; 44:517-521.

[92] Tsai, F. J., Lee, Y. C., Chang, J. S., et al. Identification of novel susceptibility Loci for
       kawasaki disease in a Han Chinese population by a genome-wide association study.
       PloS One 2011; 6:e16853.

[93] Matsuda I., Hattori, S., Nagata, N., et al. HLA antigens in mucocutaneous lymph node
       syndrome. Am. J. Dis. Child 1977; 131:1417-1418.

[94] Kato, S., Kimura, M., Tsuji, K., et al. HLA antigens in Kawasaki disease. Pediatrics
       1978; 61:252-255.

[95] Kaslow, R. A., Bailowitz, A., Lin, F. Y., et al. Association of epidemic Kawasaki
       syndrome with the HLA-A2, B44, Cw5 antigen combination. Arthritis Rheum. 1985;
       28:938-940.

[96] Krensky, A. M., Berenberg, W., Shanley, K., et al. HLA antigens in mucocutaneous
       lymph node syndrome in New England. Pediatrics 1981; 67:741-743.

[97] Krensky, A. M., Grady, S., Shanley, K. M., et al. Epidemic and endemic HLA-B and
       DR associations in mucocutaneous lymph node syndrome. Hum. Immunol. 1983; 6:75-
       77.

[98] Yan, Y., Ma, Y., Liu, Y., et al. Combined analysis of genome-wide-linked
       susceptibility loci to Kawasaki disease in Han Chinese. Hum. Genet. 2013; 132:669-
       680.

[99] Arj-Ong, S., Thakkinstian, A., McEvoy, M., et al. A systematic review and meta-
       analysis of tumor necrosis factor alpha-308 polymorphism and Kawasaki disease.
       Pediatri. Int. 2010; 52:527-532.

[100] Biezeveld, M. H., Geissler, J., Weverling, G. J., et al. Polymorphisms in the mannose-
       binding lectin gene as determinants of age-defined risk of coronary artery lesions in
       Kawasaki disease. Arthritis Rheum. 2006; 54:369-376.

[101] Biezeveld, M. H., Kuipers, I. M., Geissler, J., et al. Association of mannose-binding
       lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet 2003;
       361:1268-1270.

[102] Breunis, W. B., Biezeveld, M. H., Geissler, J., et al. Polymorphisms in chemokine
       receptor genes and susceptibility to Kawasaki disease. Clin. Exp. Immunol. 2007; 150:
       83-90.

[103] Breunis, W. B., Biezeveld, M. H., Geissler, J., et al. Vascular endothelial growth factor
       gene haplotypes in Kawasaki disease. Arthritis Rheum. 2006; 54:1588-1594.

[104] Burns, J. C., Shimizu, C., Gonzalez, E., et al. Genetic variations in the receptor-ligand
       pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki
       disease. J. Infect. Dis. 2005; 192:344-349.

[105] Burns, J. C., Shimizu, C., Shike, H., et al. Family-based association analysis implicates
       IL-4 in susceptibility to Kawasaki disease. Genes Immun. 2005; 6:438-444.

[106] Hsueh, K. C., Lin, Y. J., Chang, J. S., et al. Association of vascular endothelial growth
       factor C-634 g polymorphism in Taiwanese children with Kawasaki disease. Pediatr.
       Cardiol. 2008; 29:292-296.

[107] Ikeda, K., Ihara, K., Yamaguchi, K., et al. Genetic analysis of MMP gene
       polymorphisms in patients with Kawasaki disease. Pediatr. Res. 2008; 63:182-185.

Complimentary Contributor Copy
   132   133   134   135   136   137   138   139   140   141   142